Literature DB >> 8379855

Aberrant tissue specific expression of the transgene in transgenic mice that carry the hepatitis B virus genome defective in the X gene.

H Nagashima1, M Imai, Y Iwakura.   

Abstract

The control mechanisms for the transgene expression in mice that carry the hepatitis B virus genome defective in the polymerase and X genes were analyzed. Ten lines of transgenic mouse were established, and in seven lines the surface and e antigens were detected in the serum. In transgenic mice from five lines examined, the transgene was markedly expressed in a broad spectrum of tissues including the kidney, heart, brain, muscle and intestine, but only poorly in the liver. In the kidney and heart the 3.5 kb and 2.1 kb mRNAs were expressed, whereas only the 0.8 kb and 4.0 kb mRNAs were detected in the testis and brain, respectively, suggesting that each of the mRNAs was transcribed through a different control mechanism. The surface, e and core antigens accumulated in the kidney and heart. DNA was hypomethylated at a region closely downstream of the enhancer in the liver, kidney and heart, and a DNase I hypersensitive site was detected upstream of the enhancer in these tissues. In the testis, however, the whole transgene was hypomethylated and the DNase I hypersensitive site was closer to the enhancer. These differences may be relevant to the preferential expression of the 0.8 kb mRNA in the testis, but cannot explain the inefficiency of transgene expression in the liver. Our observations suggest that the X protein is required for efficient expression of the viral gene in the liver but not in other tissues.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8379855     DOI: 10.1007/bf01309547

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  47 in total

1.  Ig/EBP-1: a ubiquitously expressed immunoglobulin enhancer binding protein that is similar to C/EBP and heterodimerizes with C/EBP.

Authors:  C Roman; J S Platero; J Shuman; K Calame
Journal:  Genes Dev       Date:  1990-08       Impact factor: 11.361

2.  Tissue preferential expression of the hepatitis B virus (HBV) surface antigen gene in two lines of HBV transgenic mice.

Authors:  R D Burk; J A DeLoia; M K elAwady; J D Gearhart
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

3.  trans-activation of viral enhancers by the hepatitis B virus X protein.

Authors:  D F Spandau; C H Lee
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

4.  Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.

Authors:  P S Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

5.  IL-6DBP, a nuclear protein involved in interleukin-6 signal transduction, defines a new family of leucine zipper proteins related to C/EBP.

Authors:  V Poli; F P Mancini; R Cortese
Journal:  Cell       Date:  1990-11-02       Impact factor: 41.582

6.  Transgenome transcription and replication in the liver and extrahepatic tissues of a human hepatitis B virus transgenic mouse.

Authors:  K B Choo; L N Liew; K Y Chong; R H Lu; W T Cheng
Journal:  Virology       Date:  1991-06       Impact factor: 3.616

7.  Nucleotide sequence of a cloned hepatitis B virus genome, subtype ayr: comparison with genomes of the other three subtypes.

Authors:  H Okamoto; M Imai; M Shimozaki; Y Hoshi; H Iizuka; T Gotanda; F Tsuda; Y Miyakawa; M Mayumi
Journal:  J Gen Virol       Date:  1986-11       Impact factor: 3.891

8.  Detection of hepatitis B virus DNA in pancreas, kidney and skin of two human carriers of the virus.

Authors:  A Dejean; C Lugassy; S Zafrani; P Tiollais; C Brechot
Journal:  J Gen Virol       Date:  1984-03       Impact factor: 3.891

9.  A transgenic mouse model of the chronic hepatitis B surface antigen carrier state.

Authors:  F V Chisari; C A Pinkert; D R Milich; P Filippi; A McLachlan; R D Palmiter; R L Brinster
Journal:  Science       Date:  1985-12-06       Impact factor: 47.728

10.  Hepatitis B virus DNA in Kaposi sarcoma.

Authors:  A Siddiqui
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

View more
  2 in total

1.  Transcription of hepatitis B virus in peripheral blood mononuclear cells from persistently infected patients.

Authors:  S Stoll-Becker; R Repp; D Glebe; S Schaefer; J Kreuder; M Kann; F Lampert; W H Gerlich
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

2.  The hepatitis B virus X protein transactivates viral core gene expression in vivo.

Authors:  K Reifenberg; H Wilts; J Löhler; P Nusser; R Hanano; L G Guidotti; F V Chisari; H J Schlicht
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.